FABBRI, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.005
EU - Europa 21.953
AS - Asia 21.477
SA - Sud America 2.368
AF - Africa 416
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 45
Totale 98.378
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.518
GB - Regno Unito 8.152
CN - Cina 6.863
SG - Singapore 6.516
IT - Italia 3.971
HK - Hong Kong 2.818
SE - Svezia 1.877
FI - Finlandia 1.856
BR - Brasile 1.835
DE - Germania 1.613
VN - Vietnam 1.595
UA - Ucraina 1.405
TR - Turchia 1.068
FR - Francia 798
RU - Federazione Russa 778
KR - Corea 670
BG - Bulgaria 510
IN - India 385
ID - Indonesia 261
BD - Bangladesh 249
CA - Canada 241
NL - Olanda 203
AR - Argentina 182
IQ - Iraq 177
IE - Irlanda 176
MX - Messico 154
JP - Giappone 139
PK - Pakistan 115
ZA - Sudafrica 108
AU - Australia 103
PL - Polonia 91
CO - Colombia 71
CL - Cile 67
AE - Emirati Arabi Uniti 66
BE - Belgio 65
RO - Romania 63
ES - Italia 62
EC - Ecuador 61
AT - Austria 56
EG - Egitto 51
MY - Malesia 51
VE - Venezuela 48
PH - Filippine 47
SA - Arabia Saudita 47
TH - Thailandia 47
MA - Marocco 46
UZ - Uzbekistan 45
IR - Iran 39
NP - Nepal 38
TN - Tunisia 38
EU - Europa 36
PY - Paraguay 36
CH - Svizzera 35
PT - Portogallo 33
JO - Giordania 31
NG - Nigeria 28
KE - Kenya 27
TW - Taiwan 27
PE - Perù 26
UY - Uruguay 25
AZ - Azerbaigian 23
CZ - Repubblica Ceca 23
AL - Albania 22
OM - Oman 22
RS - Serbia 21
DZ - Algeria 20
SI - Slovenia 20
BY - Bielorussia 19
CR - Costa Rica 18
IL - Israele 18
LT - Lituania 18
BO - Bolivia 16
ET - Etiopia 16
BH - Bahrain 14
DK - Danimarca 14
LB - Libano 14
KZ - Kazakistan 13
SY - Repubblica araba siriana 13
AO - Angola 12
HN - Honduras 12
KG - Kirghizistan 12
SN - Senegal 12
HR - Croazia 11
DO - Repubblica Dominicana 10
JM - Giamaica 10
LV - Lettonia 9
PA - Panama 9
GE - Georgia 8
HU - Ungheria 8
NI - Nicaragua 8
QA - Qatar 8
CI - Costa d'Avorio 7
EE - Estonia 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
GR - Grecia 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BS - Bahamas 5
Totale 98.248
Salva come PNG Salva come JPEG
Città #
Southend 6.009
Fairfield 5.795
Ashburn 4.471
Woodbridge 4.243
Singapore 4.177
Jacksonville 3.092
Houston 3.088
Santa Clara 2.994
Hefei 2.808
Hong Kong 2.767
Chandler 2.262
Seattle 2.082
Dearborn 1.993
Wilmington 1.986
Cambridge 1.901
Ann Arbor 1.870
San Jose 1.517
Helsinki 1.353
London 1.290
Beijing 1.076
Nyköping 900
The Dalles 784
Chicago 723
Modena 677
Seoul 638
Los Angeles 623
San Diego 586
Princeton 556
Izmir 503
Sofia 499
Des Moines 495
Council Bluffs 492
Eugene 484
Ho Chi Minh City 478
Milan 438
Hanoi 400
Lauterbourg 397
New York 339
Salt Lake City 293
Buffalo 287
Rome 255
Moscow 222
Dallas 210
Shanghai 178
Columbus 177
Dublin 172
São Paulo 167
Tampa 148
Elk Grove Village 128
Frankfurt am Main 121
Jakarta 118
Redwood City 117
Falls Church 116
Tokyo 99
Guangzhou 97
Norwalk 97
Boardman 88
Da Nang 86
Nanjing 84
Kent 83
Palermo 82
Grafing 77
Warsaw 74
Sterling 72
Haiphong 65
Orem 65
Baghdad 64
Miano 62
Kunming 61
Atlanta 60
Brooklyn 60
San Francisco 60
Lancaster 59
Phoenix 58
Falkenstein 56
Amsterdam 55
Chennai 55
Naples 52
Mexico City 49
Jinan 47
Mumbai 47
Verona 46
Bari 45
Kilburn 45
Miami 45
Philadelphia 45
Rio de Janeiro 44
Wuhan 44
Jersey City 43
Boston 42
Brussels 42
Detroit 42
Bologna 40
Munich 40
Washington 40
Belo Horizonte 39
Curitiba 39
Florence 39
Dhaka 38
Melbourne 38
Totale 72.205
Salva come PNG Salva come JPEG
Nome #
Medicina Interna Sistematica 2.071
Asma bronchiale 657
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 478
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 474
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 450
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 436
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary 413
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 404
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 394
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 379
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 378
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 358
Effects of a walking aid in COPD patients receiving oxygen therapy 355
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 355
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 354
Chronic Lung Disease in HIV Patients 339
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 337
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 333
Update in Chronic Obstructive Pulmonary Disease 2005 330
La broncopneumopatia cronica ostruttiva nell'anziano 329
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 318
Update in chronic obstructive pulmonary disease 2006 314
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 314
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 313
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 313
Treatment of chronic obstructive pulmonary disease and its comorbidities 313
Cellular and structural bases of chronic obstructive pulmonary disease 310
Roflumilast:un nuovo farmaco per il trattamento della BPCO 309
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial 309
From COPD to chronic systemic inflammatory syndrome? 308
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 307
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 307
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma 306
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 305
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial 304
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 303
Complex chronic co-morbidities of COPD 302
Breakthroughs in internal and respiratory medicine 302
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 301
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States 301
Insufficienza Respiratoria acuta e cronica (cap.21). 298
Inhaled Corticosteroids in COPD: Pros and Cons. 297
Prognostic role of clusterin in resected adenocarcinomas of the lung. 297
Chronic critical illness: the price of survival 297
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 294
Clusterin (CLU) and lung cancer 290
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials 284
Benralizumab: for asthma, not yet for COPD 283
Macrolides in the treatment of asthma and cystic fibrosis 282
How to Integrate Multiple Comorbidities in Guideline Development 281
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 281
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 279
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 275
Early diagnosis of subclinical multi drug-resistant tuberculosis 270
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 270
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts. 269
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 269
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma 267
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. 267
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 267
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies 265
Tiotropium versus salmeterol for the prevention of exacerbations of COPD 265
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 265
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 265
Pathophysiology of exacerbations of chronic obstructive pulmonary disease 263
Sarcoidosis: challenging diagnostic aspects of an old disease. 262
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. 261
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa 258
Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate 258
Eosinophilia in asthma: the easy way is not always the best 258
Asthma in the elderly: what we know and what we have yet to know 258
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 255
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 255
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. 254
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 253
Blood tests for diagnosis of tuberculosis - Reply 252
The pharmacoepidemiology of COPD: recent advances and methodological discussion. 250
Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. 249
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial 248
Airway eosinophilia in chronic bronchitis during exacerbations. 248
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy 247
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 247
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing 246
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 246
Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial 245
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma 244
Chronic disease in the elderly: back to the future of internal medicine. 244
Effect of antiasthma drugs on asthmatic reactions induced by toluene diisocyanate in sensitized subjects. 243
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. 243
Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. 242
Significant chronic airway abnormalities in never-smoking HIV-infected patients 242
Airway inflammation in occupational asthma. 240
Effects of early inpatient rehabilitation after acute exacerbation of COPD 240
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 240
Smoking, Not COPD, as the Disease 239
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 237
Intrapulmonary percussive ventilation in tracheostomized patients: A randomized controlled trial 236
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma 236
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease 236
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum. 234
Totale 31.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 381.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 381.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021965 0 0 0 0 0 0 0 0 0 0 499 466
2021/20228.366 186 1.276 963 673 216 357 636 409 851 561 1.330 908
2022/20236.892 803 496 362 556 845 1.260 116 733 1.035 118 316 252
2023/20244.221 176 311 297 440 772 440 423 530 148 122 143 419
2024/202514.078 611 264 175 868 2.559 1.611 887 778 1.851 905 1.727 1.842
2025/202626.066 1.693 1.357 3.209 2.727 3.304 2.789 4.155 1.475 2.387 2.222 748 0
Totale 98.849